AIM2 Toward New Treatments To Thwart Colon Cancer
Saturday, June 27, 2015 - 13:10
in Health & Medicine
Scientists at St. Jude Children's Research Hospital have discovered how an immune system protein, called AIM2 (Absent in Melanoma 2), plays a role in determining the aggressiveness of colon cancer. They found that AIM2 deficiency causes uncontrolled proliferation of intestinal cells. Surprisingly, they also discovered that AIM2 influences the microbiota -- the population of gut bacteria -- apparently fostering the proliferation of 'good' bacteria that can protect against colon cancer. The team, led by Thirumala-Devi Kanneganti, Ph.D., a member of the St. Jude Department of Immunology, said that the findings could have important applications for prevention, prognosis and treatment. read more